Nav: Home

Heparin derived from cattle is equivalent to heparin from pigs, study finds

October 05, 2016

MAYWOOD, IL - As demand for the widely used blood thinning drug heparin continues to grow, experts worry of possible shortages of the essential medication.

Heparin is primarily derived from pigs, and to reduce the risk of shortages, cattle have been proposed as an additional source. A new study co-authored by Loyola University Chicago Stritch School of Medicine researchers has found that heparin derived from cattle (known as bovine heparin) has equivalent anti-clotting properties to heparin derived from pigs (porcine heparin).

The study found minor differences in the structural and molecular characteristics of bovine and porcine heparin, but these differences did not significantly affect the drug's anticoagulant properties.

The study co-authored by Jawed Fareed, PhD, and colleagues is published in the journal Clinical and Applied Thrombosis/Hemostasis. Fareed is a professor in the Department of Molecular Pharmacology and Therapeutics and Department of Pathology and director of the Hemostasis and Thrombosis Research Program at Loyola University Chicago Stritch School of Medicine.

Fareed is one of the world's leading heparin scientists. He has researched heparin for 40 years and is the author or co-author of more than 200 scientific papers on heparin.

The study is titled "Analysis of Heparins Derived from Bovine Tissues and Comparison to Porcine Intestinal Heparins." Other Loyola co-authors are Debra Hoppensteadt, PhD and Walter Jeske, PhD. Nine other co-authors, including corresponding author Robert J. Linhardt, PhD, are with the Rensselaer Polytechnic Institute.

Heparin is an anticoagulant (blood thinner), and one of the world's most commonly used drugs. Heparin is used to prevent or treat blood clots in veins, arteries and lungs and used before surgery to reduce the risks of clots. Heparin is injected or administered intravenously.

Heparin also is used in devices that come in contact with blood, such as kidney dialysis machines and test tubes.

Heparin used in the U.S. now comes from the intestines of pigs that are slaughtered for meat. (The heparin is derived from what would otherwise be a waste product.) Seventy-five percent of the heparin used in the U.S. comes from China, which is the world's largest pork producer.

"Because heparin is a widely used essential drug with no medical alternatives in certain clinical situations, the U.S. healthcare system could be vulnerable to fluctuations in the crude heparin supply," according to the Food and Drug Administration's Center for Drug Evaluation and Research. The center is evaluating the possible reintroduction of bovine heparin in order to address possible shortages or contamination of the global porcine heparin supply.

Bovine heparin could be derived from the intestines and lungs of cattle that are slaughtered for meat. Because cows are larger than pigs, one cow can produce much more heparin than one pig.

Bovine heparin was voluntarily withdrawn from the market during the 1980s due to worries that it could, in rare cases, cause thrombocytopenia (shortage of platelets leading to bleeding and bruising) or be contaminated with bovine spongiform encephalopathy (mad cow disease). Those fears have been put to rest by advancements in manufacturing and quality control that have resulted in purer forms of heparin, Fareed said.

Some experts remain skeptical about bovine heparin because it has a different chemical structure than porcine heparin. To examine this question, Fareed and colleagues compared individually manufactured batches of bovine heparin with individually manufactured batches of porcine heparin. The anticoagulant activities of the two groups were found to be equivalent.
The study was supported by grants from the National Institutes of Health and National Science Foundation.

Loyola University Health System

Related Heparin Articles:

No difference in rate of adverse cardiovascular events when comparing anticoagulants
In patients undergoing transradial primary percutaneous coronary intervention (PCI) for ST elevation myocardial infarction (STEMI), there was no significant difference in the rate of a composite of death, myocardial infarction and stroke whether they were anticoagulated with bivalirudin or unfractioned heparin, according to a study today in JACC: Cardiovascular Interventions.
Smart patch releases blood thinners as needed
An interdisciplinary team of researchers has developed a smart patch designed to monitor a patient's blood and release blood-thinning drugs as needed to prevent the occurrence of dangerous blood clots.
Two differing medications used during heart procedure are both safe and effective, study finds
Two differing blood clot prevention medications are just as safe and effective for patients undergoing percutaneous coronary intervention, a non-surgical procedure to open blood vessels narrowed by plaque buildup, according to a new study.
Still wary of heparin from China, US considers options
China's appetite for pigs fills dinner plates, but it also fills half the world's orders for heparin, an anticoagulant made from the animals' intestines.
Heparin derived from cattle is equivalent to heparin from pigs, study finds
As demand for the widely used blood-thinning drug heparin continues to grow, experts worry of possible shortages.
Snake venom could make surgery safer for patients on blood thinners
Preventing blood clots with drugs such as heparin has become a common practice for fighting some heart and lung conditions, and for certain surgeries.
Treatment for heparin-induced blood disorder revealed in structure of antibody complex
A potential treatment for a serious clotting condition that can strike patients who receive heparin to treat or prevent blood clots may lie within reach by elucidating the structure of the protein complex at its root.
Which blood thinner works better during stent placement? It's still a toss-up
A large, ambitious contrast of blood-thinning medications used during cardiac stent placement suggests that a very expensive drug offers no clear safety benefits over a much more affordable option, according to a prominent North Shore-LIJ researcher and cardiologist.
Study compares heparin to warfarin for treatment of blood clots in patients with cancer
Among patients with active cancer and acute symptomatic venous thromboembolism (VTE; blood clots in the deep veins), the use of the low molecular-weight heparin tinzaparin daily for six months compared with warfarin did not significantly reduce recurrent VTE and was not associated with reductions in overall death or major bleeding, but was associated with a lower rate of clinically relevant nonmajor bleeding, according to a study in the Aug.
Common drug is re-engineered to improve surgery outcomes
A Northwestern University research team attached a gas molecule to protamine sulfate, creating a new nitric oxide generator that could potentially reduce bleeding complications during surgery.

Related Heparin Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#529 Do You Really Want to Find Out Who's Your Daddy?
At least some of you by now have probably spit into a tube and mailed it off to find out who your closest relatives are, where you might be from, and what terrible diseases might await you. But what exactly did you find out? And what did you give away? In this live panel at Awesome Con we bring in science writer Tina Saey to talk about all her DNA testing, and bioethicist Debra Mathews, to determine whether Tina should have done it at all. Related links: What FamilyTreeDNA sharing genetic data with police means for you Crime solvers embraced...